76 related articles for article (PubMed ID: 20804050)
1. [Markers of malignant growth as a component of morphologic pattern in human biological fluids].
Shatokhina SN; Shabalin VN
Vopr Onkol; 2010; 56(3):293-300. PubMed ID: 20804050
[No Abstract] [Full Text] [Related]
2. The excretion of 17-ketosteroids in patients suffering from mastopathia fibrocystica and mammary carcinomas.
Görlich M; Heise E; Pradja N; Hindy I
Arch Geschwulstforsch; 1975; 45(7):648-57. PubMed ID: 132149
[TBL] [Abstract][Full Text] [Related]
3. [The level of follicle stimulating activity in precancer and cancer of the breast].
Iskakova KI; Mezinova NN
Vopr Onkol; 1973; 19(9):15-9. PubMed ID: 4788392
[No Abstract] [Full Text] [Related]
4. [Influence of age and menopause duration on the excretion of steroid hormones in precancerous conditions and cancer of the breast].
Bogdanova AG
Vopr Onkol; 1974 Oct; 20(7):13-8. PubMed ID: 4277856
[No Abstract] [Full Text] [Related]
5. [Urinary estrogen excretion in preneoplastic breast diseases].
Kozhnazarova IuS; Mezinova NN; Remizova MG; Ikhsanova ST
Vopr Onkol; 1972; 18(10):23-6. PubMed ID: 4662530
[No Abstract] [Full Text] [Related]
6. Urinary tissue factor levels in patients with breast and colorectal cancer.
Lwaleed BA; Chisholm M; Francis JL
J Pathol; 1999 Feb; 187(3):291-4. PubMed ID: 10398081
[TBL] [Abstract][Full Text] [Related]
7. Copper, zinc and superoxide dismutase in precancerous, benign diseases and gastric, colorectal and breast cancer.
Magálová T; Bella V; Brtková A; Beno I; Kudlácková M; Volkovová K
Neoplasma; 1999; 46(2):100-4. PubMed ID: 10466433
[TBL] [Abstract][Full Text] [Related]
8. Significance of serum ferritin and lactate dehydrogenase in benign and malignant disease of breast.
Kher A; Moghe G; Deshpande A
Indian J Pathol Microbiol; 1997 Jul; 40(3):321-6. PubMed ID: 9354001
[TBL] [Abstract][Full Text] [Related]
9. High BCM serum levels in patients with non breast tumors: first results.
Allende T; Vizoso F; Roiz C; Fueyo A; Lennartz L; Ruibal A
Bull Cancer; 1990; 77(10):1031-2. PubMed ID: 2249013
[No Abstract] [Full Text] [Related]
10. [Studies of the suitability of zinc determination in granulocytes as a screening test for the detection of malignancies and precancerous conditions].
zur Horst-Meyer H; Borchard N; Welzel P
Z Gesamte Inn Med; 1970 May; 25(10):437-40. PubMed ID: 5523559
[No Abstract] [Full Text] [Related]
11. Evaluation of mucinous-like cancer antigen (MCA) in women with breast disease: preliminary results.
Valenti G; Zanardi S; Valtolina M; Bombardieri E; Boccardo F
Cancer Detect Prev; 1991; 15(4):285-9. PubMed ID: 1794135
[TBL] [Abstract][Full Text] [Related]
12. Serum c-erbB-2 protein in breast cancer patients.
Chearskul S; Sinlarat P; Bhothisuwan K; Churintrapun M; Ornrhebroi S; Klinsala N; Sungkabunchoo S
J Med Assoc Thai; 2000 Aug; 83(8):886-93. PubMed ID: 10998842
[TBL] [Abstract][Full Text] [Related]
13. [Prolactin. Radioimmunoassay in female breast cancers and benign mastopathies].
Gorins A; Netter A
Nouv Presse Med; 1974 Jan; 3(2):73-5. PubMed ID: 4815434
[No Abstract] [Full Text] [Related]
14. Monocyte tissue factor levels in cancer patients.
Lwaleed BA; Francis JL; Chisholm M
Saudi Med J; 2000 Aug; 21(8):722-9. PubMed ID: 11423883
[TBL] [Abstract][Full Text] [Related]
15. [Serum and urine glucuronic acid in breast cancer and precancer].
Al'pert AE; Lunts AM
Vopr Onkol; 1971; 17(11):28-31. PubMed ID: 5157636
[No Abstract] [Full Text] [Related]
16. Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer.
Toi M; Taniguchi T; Ueno T; Asano M; Funata N; Sekiguchi K; Iwanari H; Tominaga T
Clin Cancer Res; 1998 Mar; 4(3):659-64. PubMed ID: 9533534
[TBL] [Abstract][Full Text] [Related]
17. [Change in erythrocyte shape during tumor growth in humans].
Kashulina AP; Tereshchenko IP; Aleksandrova LM
Patol Fiziol Eksp Ter; 1980; (3):53-5. PubMed ID: 7402707
[No Abstract] [Full Text] [Related]
18. Super-sensitive prostate-specific antigen (PSA) in serum of women with benign breast disease or breast cancer.
Hautmann S; Huland E; Grupp C; Haese A; Huland H
Anticancer Res; 2000; 20(3B):2151-4. PubMed ID: 10928169
[TBL] [Abstract][Full Text] [Related]
19. [Changes in the daily rhythm of plasma 11-hydroxycorticosteroids in relation to malignant neoplasms and precancerous conditions in otolaryngology].
Cisárik A; Valdman V
Cesk Otolaryngol; 1982 Apr; 31(2):98-101. PubMed ID: 7201355
[No Abstract] [Full Text] [Related]
20. Total and lipid-bound serum sialic acid in benign and malignant breast disease.
Romppanen J; Eskelinen M; Tikanoja S; Mononen I
Anticancer Res; 1997; 17(2B):1249-53. PubMed ID: 9137482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
